Compound information
- Natural Products
- ZC104697
- Molecular Formula
- C16H25BN2O7S
- Molecular Weight
- 400.14755254 g/mol
- Structure
-
- IUPAC Name
- [5-(4-tert-butoxycarbonylpiperazin-1-yl)sulfonyl-2-methoxy-phenyl]boronic acid
- InChI
- InChI=1S/C16H25BN2O7S/c1-16(2,3)26-15(20)18-7-9-19(10-8-18)27(23,24)12-5-6-14(25-4)13(11-12)17(21)22/h5-6,11,21-22H,7-10H2,1-4H3
- InChI Key
- NWTPQIPMKBUCLO-UHFFFAOYSA-N
- SMILES
- COc1ccc(S(=O)(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1B(O)O
- Source
- ZINC000230550770
Warheads
- Carbamate
-
- Boronic Acid
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 27 | Ring Count | 2 |
Heteroatom Count | 11 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 7 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 116.61 Å2 | LogP | 1.341 |
LogS | -3.132 | LogD | 2.229 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.051 | Pgp substrate | 0.05 |
HIA | 0.908 | F20 % | 0.129 |
F30 % | 0.0 | Caco-2 | -4.724 |
MDCK | -5.262 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.931 | PPB | 93.614 |
VD | 1.487 | Fu | 0.774 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.372 |
CYP2A6 substrate | 0.394 | CYP2B6 substrate | 0.501 |
CYP2C19 inhibitor | 0.13 | CYP2C19 substrate | 0.596 |
CYP2C8 substrate | 0.566 | CYP2C9 inhibitor | 0.016 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.035 |
CYP2D6 substrate | 0.659 | CYP2E1 substrate | 0.247 |
CYP3A4 inhibitor | 0.067 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.472 | CL | 6.443 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.05 | Hepatotoxicity | 0.943 |
Mutagenicity | 0.025 | Rat Oral Acute Toxicity | 0.044 |
FDAMDD | 0.027 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.551 | Eye Corrosion | 0.002 |
Eye Irritation | 0.186 | Respiratory Toxicity | 0.169 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.923 | IGC50 | 1.954 |
LC50FM | 2.775 | LC50DM | 0.843 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.208 | NR-AR-LBD | 0.861 |
NR-AhR | 0.158 | NR-Aromatase | 0.973 |
NR-ER | 0.366 | NR-ER-LBD | 0.622 |
NR-PPAR-gamma | 0.799 | SR-ARE | 0.879 |
SR-ATAD5 | 0.861 | SR-HSE | 0.985 |
SR-MMP | 0.031 | SR-p53 | 0.996 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.